Carbinoxamine
Back to searchMolecule Structure
Scientific Name
Carbinoxamine
Description of the Drug
Carbinoxamine is a first generation antihistamine used to treat allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, allergic reactions, and mild allergic reactions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00748
http://www.drugbank.ca/drugs/DB00748
Brand Name(s)
Not Available
Company Owner(s)
Cypress Pharmaceutical Inc, Invagen Pharmaceuticals Inc, Mikart Llc, Aytu Bioscience Inc, Mission Pharmacal Co, Mcneil Pharmaceutical Co Div Mcneilab Inc, Vintage Pharmaceuticals, Ortho Mcneil Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5070 | |
| PharmGKB | PA164746898 | |
| Human Metabolome Database | HMDB0014886 | |
| WDI | CARBINOXA | ROTOXAMIN |
| DrugBank | DB00748 | |
| PubChem: Thomson Pharma | 16888880 | |
| PubChem | 2564 | |
| LINCS | LSM-1435 | |
| Nikkaji | J7.994D | J6.006B |
| EPA CompTox Dashboard | DTXSID4022737 | |
| DrugCentral | 499 | |
| ChemicalBook | CB4875334 | |
| Guide to Pharmacology | 7139 | |
| GSRS | 99a8dd99-8018-4c1e-8e18-af8b6f467ac1 | |
| rxnorm | CARBINOXAMINE | CARBINOXAMINE MALEATE |
| KEGG Ligand | C06871 | |
| ChEBI | 3398 |
